These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1377 related items for PubMed ID: 10434313

  • 1. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1101-18. PubMed ID: 10434313
    [Abstract] [Full Text] [Related]

  • 2. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):213-27. PubMed ID: 11260802
    [Abstract] [Full Text] [Related]

  • 3. Neuropathological spectrum of synucleinopathies.
    Jellinger KA.
    Mov Disord; 2003 Sep 28; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA, Love S.
    J Neuropathol Exp Neurol; 2007 Nov 28; 66(11):1019-26. PubMed ID: 17984683
    [Abstract] [Full Text] [Related]

  • 5. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ, Hausser-Hauw C, Duyckaerts C.
    Rev Neurol (Paris); 2003 Nov 28; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [Abstract] [Full Text] [Related]

  • 6. Anatamopathological spectrum of tauopathies.
    Revesz T, Holton JL.
    Mov Disord; 2003 Sep 28; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [Abstract] [Full Text] [Related]

  • 7. A Drosophila model of Parkinson's disease.
    Feany MB, Bender WW.
    Nature; 2000 Mar 23; 404(6776):394-8. PubMed ID: 10746727
    [Abstract] [Full Text] [Related]

  • 8. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M, Probst A.
    IUBMB Life; 2003 Jun 23; 55(6):299-305. PubMed ID: 12938731
    [Abstract] [Full Text] [Related]

  • 9. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR, Lang AE.
    Ann Neurol; 2006 Mar 23; 59(3):449-58. PubMed ID: 16489609
    [Abstract] [Full Text] [Related]

  • 10. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 23; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 11. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A, Lippa CF, Lee VM, Trojanowski JQ.
    Arch Neurol; 2004 Dec 23; 61(12):1915-9. PubMed ID: 15596612
    [Abstract] [Full Text] [Related]

  • 12. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
    Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM.
    Cell Death Differ; 1998 Oct 23; 5(10):832-7. PubMed ID: 10203692
    [Abstract] [Full Text] [Related]

  • 13. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.
    Brain; 2010 Jan 23; 133(Pt 1):172-88. PubMed ID: 19903734
    [Abstract] [Full Text] [Related]

  • 14. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
    Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T.
    Nat Cell Biol; 2002 Feb 23; 4(2):160-4. PubMed ID: 11813001
    [Abstract] [Full Text] [Related]

  • 15. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T.
    Acta Neuropathol; 2002 Sep 23; 104(3):225-30. PubMed ID: 12172907
    [Abstract] [Full Text] [Related]

  • 16. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
    Goedert M.
    Curr Opin Genet Dev; 2001 Jun 23; 11(3):343-51. PubMed ID: 11377973
    [Abstract] [Full Text] [Related]

  • 17. Heredity in Parkinson's disease: new findings.
    Lev N, Melamed E.
    Isr Med Assoc J; 2001 Jun 23; 3(6):435-8. PubMed ID: 11433638
    [Abstract] [Full Text] [Related]

  • 18. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA.
    Acta Neuropathol; 2003 Sep 23; 106(3):191-201. PubMed ID: 12845452
    [Abstract] [Full Text] [Related]

  • 19. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH, Giasson BI, Lee VM.
    Curr Top Dev Biol; 2004 Sep 23; 60():17-54. PubMed ID: 15094295
    [Abstract] [Full Text] [Related]

  • 20. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM.
    Exp Neurol; 2004 Jun 23; 187(2):279-88. PubMed ID: 15144854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.